Last 29.75 INR
Change Today -2.75 / -8.46%
Volume 109.0K
PDI On Other Exchanges
Symbol
Exchange
PDI is not on other exchanges.
As of 7:06 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

parenteral drugs india ltd (PDI) Snapshot

Open
32.25
Previous Close
32.50
Day High
33.80
Day Low
29.05
52 Week High
07/18/13 - 74.60
52 Week Low
07/3/14 - 24.15
Market Cap
887.0M
Average Volume 10 Days
374.1K
EPS TTM
-41.69
Shares Outstanding
29.8M
EX-Date
09/13/10
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PARENTERAL DRUGS INDIA LTD (PDI)

Related News

No related news articles were found.

parenteral drugs india ltd (PDI) Related Businessweek News

No Related Businessweek News Found

parenteral drugs india ltd (PDI) Details

Parenteral Drugs (India) Limited operates as a healthcare company in India and internationally. The company researches, produces, and manufactures pharmaceutical products, including intravenous infusion, tablets, capsules, liquids syrups, injections, etc. Its products comprise solid and liquid orals, I.V. fluids, oncology products, and critical care products. The company was founded in 1983 and is based in Indore, India.

Founded in 1983

parenteral drugs india ltd (PDI) Top Compensated Officers

Managing Director and Director
Total Annual Compensation: 2.8M
Chief Executive and Whole-Time Director
Total Annual Compensation: 2.6M
Whole-Time Director
Total Annual Compensation: 1.4M
Compensation as of Fiscal Year 2013.

parenteral drugs india ltd (PDI) Key Developments

Parenteral Drugs (India) Limited Announces Resignation of Satish Moreshwar Joshi as Nominee Director

Parenteral Drugs (India) Limited announced that Mr. Satish Moreshwar Joshi, nominee director of the company has tendered his resignation from directorship of the company with effect from June 30, 2014 due to his personal priorities.

Parenteral Drugs (India) Limited Announces Audited Standalone Financial Results for the Fourth Quarter and Full Year Ended March 31, 2014

Parenteral Drugs (India) Limited announced audited standalone financial results for the fourth quarter and full year ended March 31, 2014. For the quarter, the company reported loss from operations before other income, interest & exceptional items of INR 269.7 million against INR 86.5 million for the same period of last year. Loss from ordinary activities before tax was INR 73.55 million against INR 159 million for the same period of last year. Net loss for the period was INR 93 million or INR 3.11 per basic and diluted share against INR 179 million or INR 6.93 per basic and diluted share for the same period of last year. Net sales/income from operations (net of excise duty) were INR 405 million against INR 518.7 million for the same period of last year. For the year, the company reported loss from operations before other income, interest & exceptional items of INR 344 million against INR 395 million for the same period of last year. Loss from ordinary activities before tax was INR 550 million against INR 817 million for the same period of last year. Net loss for the period was INR 587 million or INR 19.69 per basic and diluted share against INR 852 million or INR 32.94 per basic and diluted share for the same period of last year. Net sales/income from operations (net of excise duty) were INR 1,865 million against INR 1,872 million for the same period of last year.

Parenteral Drugs (India) Limited, Board Meeting, May 30, 2014

Parenteral Drugs (India) Limited, Board Meeting, May 30, 2014., at 11:00 Indian Standard Time.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PDI:IN 29.75 INR -2.75

PDI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PDI.
View Industry Companies
 

Industry Analysis

PDI

Industry Average

Valuation PDI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.3x
Price/Book 0.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PARENTERAL DRUGS INDIA LTD, please visit www.pdindia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.